All Type of News
Binex to export Remicade biosimilar to Russia
Binex said Thursday it will export Remicade biosimilar to Pharmstandard, Russia’s leading drugmaker.
Developed by Johnson & Johnson, Remicade is a blockbuster rheumatoid arthritis drug.
The Korean pharmaceutical...
Patients, civic group call for issuance of detailed written form of drug information
A patient group and the Green Consumer Association said Thursday that more detailed drug information should be provided to patients in writing to enhance the patient’s right to know, in addition to the health regulato...
Korean drug makers blast KRPIA’s plan to change name
Korean drug firms strongly protested the Korean Research-based Pharmaceutical Industry Association (KRPIA) renewing its plan to change its name.
The KRPIA is considering changing its Korean name by deleting “multin...
Karolinska Institutet seeks partnership with Kael Gemvax over GV1001
Sweden based Karolinska Institutet, one of Europe's largest and most prestigious medical universities, sent out a letter of intent (LOI) to Kael Gemvax to jointly conduct Phase II clinical trial of GV 1001, Kael Gemva...
Wholesalers in hot seat over mandatory warehouse provision
Starting next April, pharmaceutical wholesalers are obliged to safeguard a drug warehouse of 80 pyung (1 pyung = 3.3 square meters).
That poses a dilemma for the Korean Pharmaceutical Wholesaler Association (KPWA),...
Boryung receives approval for additional Indication of Stogar tablets
Boryung Pharmaceutical Co. announced today that it has received approval from the Ministry of Food and Drug Safety for gastro-esophagegus reflux disease (GERD) as an additional indication of Stogar (lafutidine) tablet...
Handok teams up with Osong Medical Foundation to develop new drugs
Handok Pharmaceutical will strengthen its new drug development business through a partnership with the Osong Medical Industry Promotion Foundation (OMIPF).
On Monday, the chairman of Handok and OMIPF chief announce...
Polarization deepens in drug industry
Gone are the times when mid- and small-sized drug firms earned profits easily by producing generics, which refer to drugs that have the same ingredients and effects as the original brand name drugs. They are now on th...
Drugmakers’ marketing expenses rise
Government-imposed price cuts of the past year had drug companies scramble to tighten their purse strings, but they perhaps considered marketing expenses as too important to rein in ― their promotional outlays have be...
Small drugmakers in dilemma over government request to go global
Globalization has been the buzzword for different sectors of Korean society for the past three decades. The domestic pharmaceutical sector is no exception.
However, the country’s small drug makers are now in a dile...
